A simple and efficient method to prepare isomorphous derivatives of protein crystals with xenon as a heavy atom is described. The method consists of exposing a crystal to xenon gas of pressures above 5atm (---0.5 MPa) for several minutes and subsequently shock-freezing the crystal to immobilize the xenon dissolved in the mother liquor and bound to the protein.
I. Introduction
The use of xenon as a heavy atom for isomorphous derivatives has a long but not very intense history in macromolecular crystallography. As early as 1965, Schoenborn, Watson & Kendrew (1965) showed by difference-Fourier synthesis that myoglobin has a specific binding site for xenon within the heine pocket. However, it took almost two decades until Tilton, Kuntz & Petsko (1984, henceforth abbreviated as TKP) studied the binding of xenon to myoglobin more systematically, and observed three additional xenon binding sites. However, these newly discovered sites were only partly occupied at xenon pressures below 0.8 MPa. TKP also recognized that xenon binding restricts the conformational freedom of myoglobin. More recently, Schiltz, Fourme, Broutin & Prang6 (1995) showed that several ~C 1997 International Union of Crystallography Printed in Great Britain -all rights reserved serine carboxypeptidases have a specific xenon binding site in the region of the catalytic triade. In another contribution the same authors (Schiltz, Prang6 & Fourme, 1994;  henceforth SPF) described a straightforward method to prepare isomorphous xenon derivatives at ambient temperatures. Since then, xenon has occasionally been used for macromolecular phase determination (e.g. Bourguet, Ruff, Chanbon, Gronemeyer & Moras, 1995; Li, Koni & Ellar, 1996; Schindelin, Kisker, Hilton, Rajagopalan & Rees, 1996) .
From a theoretical perspective xenon appears to be an ideal complement to the traditional heavy-atom compounds in protein crystallography (Blundell & Johnson, 1976) : the interaction between xenon and the protein is confined to (inherently weak) dispersion forces, and does not involve electrostatic interactions. For this reason, xenon should bind to different locations of the protein compared with most other heavy-atom compounds. The weakness of the interaction between xenon and the protein makes it unlikely that xenon interferes with crystal contacts, i.e. xenon derivatives usually show good isomorphicity with the native crystal, resulting in high phasing power. Thus, Vitali, Robbins, Almo & Tilton (1991) were able to show that a single data set from a xen?q derivative is sufficient to obtain an interpretable electron-density map for sperm-whale myoglobin, making use of the appreciable anomalous dispersion of xenon at the Cu Ks wavelength (f'=-0.783, f"= 7.384; International Tables for Crystallography, 1995) . Moreover, xenon has little effect on the pH or ionic strength of the mother liquor. The weakness of the interactions between xenon and proteins, however, necessitates a rather large xenon concentration in the crystal's mother liquor to enforce sufficient occupation of a potential binding site (Ewing & Maestas, 1970) . Therefore, all pertinent experiments reported in the literature had to make use of high-pressure equipment.
Typically, xenon derivatives have until now been prepared by mounting a crystal in a conventional X-ray quartz capillary and applying a xenon pressure of 0.5-1.0 MPa. This pressure has to be maintained throughout the subsequent X-ray diffraction experiment, carried out at ambient temperature or at 269K. A simple and O. SAUER, A. SCHMIDT AND C. KRATKY 477 elegant design for such a high-pressure xenon cell was described by SPF. While this technique in principle permits the subsequent collection of native and xenon derivative data from the same crystal (provided radiation damage is sufficiently slow), it has a number of serious drawbacks: the mechanical stability of X-ray capillaries, the absorption of X-rays by the compressed xenon gas and the possibility of the damage of the protein crystal by the formation of a xenon hydrate (SPF) limit the accessible pressure range to below 1.0 MPa, particularly when using Cu K0~ radiation. Already at these pressures, absorption may introduce a sizeable systematic error into the intensity data. Moreover (and perhaps more seriously), during the last decade, techniques have been developed to cool protein crystals to cryogenic temperatures (--, 100 K), and to collect diffraction data at these conditions (Rodgers, 1994; Hope, 1988 Hope, , 1990 Hope et aL, 1989; Teng, 1990) . Protein cryocrystallography has a number of compelling advantages over the traditional methods of mounting protein crystals into thin-walled X-ray capillaries and collecting diffraction data under ambient conditions, e.g. drastically reduced radiation damage, less absorption, lower background, sometimes diffraction to higher crystallographic resolution. For this reason the majority of protein crystalstructure determinations are today based on data collected at cryogenic temperatures. This makes the collection of room-temperature xenon-derivative data problematic, even in cases where radiation damage would permit the collection of a full data set from one derivative crystal. Moreover, the need to maintain elevated xenon pressure during the full duration of the X-ray data collection is experimentally cumbersome, which is probably the main reason why xenon has been so little used as a heavy atom in macromolecular crystallography.
On top of its use as a 'classical' heavy atom, there are several other ways in which xenon can help to solve and interpret crystal structures of biological macromolecules. In view of its chemical inertness and good solubility, xenon suggests itself for contrast-variation experiment to determine phases of low-angle reflections (Carter, Crumley, Coleman, Hage & Bricogne, 1990) , possibly also by exploiting anomalous diffraction (Fourme, Shepard, Kahn, l'Hermite & Li de La Sierra, 1996) . Due to its highly different solubility in polar and apolar solvents (Weast & Astle, 1980; Pollack, Kennan, Himm & Can', 1989) , we also expect and propose to use xenon for the crystallographic imaging of disordered areas of lipids or detergents in crystals of membrane proteins, which has so far been the exclusive domain of low-angle neutron diffraction in combination with contrast variation (Timmins, Pebay-Peyroula & Welte, 1994) .
Lastly, xenon has a considerable medical relevance in its own right, which merits the study of its interaction with biological molecules. It is used in medical diagnostics to selectively enhance the contrast in X-ray and magnetic resonance (MR) tomography (Albert et al., 1994; Pietrass & Gaede, 1995) , and it is a potent and potentially useful anaesthetic (Cullen & Gross, 1951) . The radioactive 133Xe is used for medical scintigraphy. Thus, the interaction of xenon with biological material is also of fundamental medical interest.
In the present communication we describe a simple technique to facilitate and extend the use of xenon in macromolecular crystallography. For this purpose we have developed two devices which permit the exposure of protein crystals to xenon pressures up to and exceeding 5.0 MPa, and to shock-freeze these crystals to cryotemperature (,-~ 100K) without significant loss of the protein-bound xenon. This technique is also well suited for studying the binding of other gases to crystalline biomolecules (Hohenester, Kriiutler & Kratky, 1991) .
General concept of the technique
The technique to observe the low-temperature X-ray diffraction of a protein with freeze-trapped xenon consists of the following sequence of steps.
(i) Soaking the protein crystal in a cryoprotectant, usually the one for shock-freezing native crystals of the same protein. Occasionally, e.g. if the mother liquor already contains a sufficient concentration of alcohols, this step can be omitted and crystals can be directly shock-frozen from their mother liquor (Rodgers, 1994) .
(ii) Mounting the crystal for subsequent low-temperature X-ray diffraction experiments, typically within a cryoloop (Teng, 1990) or a similar device (Hope et al., 1989) , which is usually attached to a metal pin. The design of the mounting pins used in our laboratory is shown in Fig. 1 .
(iii) Insertion of the metal pin with the native crystal in its cryoloop into a high-pressure cell. After sealing the cell, an appropriate xenon pressure (typically 0.5-5.0 MPa) is applied for a time sufficient to allow diffusion of xenon into the crystal and binding to the protein (typically 1-30 min).
(iv) Fast release of xenon pressure, removal of the X-ray pin from the pressure cell and immediate shockfreezing to cryotemperature (e.g. by dumping into liquid nitrogen).
(v) Transfer of the frozen crystal to the cold-stream cryostat of an X-ray goniometer avoiding warm-up. Several techniques have been described for this low- temperature transfer (e.g. Rodgers, 1994; Boese & Bl~iser, 1989) .
In order for this scheme to work and to permit the observations of freeze-trapped xenon within a protein crystal, a number of assumptions (whose validity will be justified by the success of our experiments) have to be fulfilled.
Firstly, xenon has to stay attached to its binding site once the crystal is cooled to cryotemperature ( ---100 K), even in the absence of external xenon pressure. This is a plausible assumption considering the very low vapour pressure of xenon at 100 K, as well as the high viscosity of the glass formed at cryogenic temperatures.
A second and less obvious assumption concerns the time required for diffusion of xenon through the surrounding mother liquor into the protein crystal and the establishment of the association equilibria for all accessible binding sites, once a cryoloop with a crystal in it is exposed to high-pressure xenon gas. While there are no accurate data available, SPF have shown for pancreatic porcine elastase crystals that these processes are complete in less than ~,20min at ambient temperature. Since we made similar observations (see below), it is reasonable to assume that xenon diffusion into a typical protein crystal and its binding to the protein is a process on the timescale of minutes.
Thirdly (and least obviously), the reverse processxenon desorption from its binding site(s) and diffusion out of the protein crystal once external xenon pressure is removed -has to proceed on a similar timescale. Thus, during the few seconds required for xenon pressure release and freeze quenching, only a small fraction of the dissolved xenon should have left the protein crystal and its surrounding mother liquor.
Design of instruments
Many of the steps outlined in the last paragraph are standard procedures for protein cryocrystallography.
However, the device to subject a protein crystal to pressurized xenon gas had to be specifically developed with the following design criteria in mind.
(i) The crystal and its surrounding cryoprotectant must not dry out during exposure to xenon gas.
(ii) Release of xenon pressure and removal of the mounting pin should be 'as fast as possible' to avoid xenon desorption.
(iii) The cell should be designed to minimize gas turbulence around the crystal during pressure changes to avoid blowing the crystal from its mount.
(iv) The total volume of the autoclave should be small to prevent excessive consumption of (expensive) xenon.
(v) It should be possible to observe the crystal through a microscope during its exposure to xenon.
(vi) The instrument should be simple to build and easy to operate.
It turned out that all six design criteria could not be equally well addressed with one single instrument. Eventually, we ended up with two devices, each of which emphasizes different criteria. The two instruments are described below. They have been designed to accept the mounting pins routinely used in our laboratory, whose design (see Fig. 1 ) follows a suggestion by Hope (1987) . The adaption of the two instruments to other shapes and sizes of manipulating pins should be straightforward. interior of the cell with the outside: one is used to connect the cell via a piece of plastic capillary tubing with standard HPLC (high-pressure chromatography) fittings to the pressure reduction valve of a xenon gas bottle, the other bore accepts the X-ray pin. Its conical inner shape and its diameter guarantee that, when the pin is fully inserted, the cryoloop is located at the centre of the pressure cell. Air-tightness is assured by an O ring, which surrounds the X-ray pin and which is squeezed between pin and metal housing by tightening of a lock screw.
The 'mark 1'pressure cell
To prepare the device for a xenon experiment, several microlitres of water are first injected into the cell in order to prevent drying of the crystal, and the system is flushed with xenon to displace the air. Next, the crystal is picked up with the cryoloop from a drop of cryoprotectant, and the metal pin is quickly inserted into the pressure cell through the appropriate bore. The lockscrew is tightened and xenon of the desired pressure is applied by opening of the xenon valve. The two glass windows of the pressure cell allow microscopic observation of the crystal during exposure. At the end of the desired exposure time, the valve on the gas bottle is closed, and the over-pressure within the cell is released by unscrewing of the connection of the capillary tubing to the pressure valve. The lock-screw is loosened, the pin is pulled out from the cell (with the help of a pin holder similar to the one shown in Fig. 3c ) and quickly dumped into liquid propane or 'kauid nitrogen. Typically, the time between the beginm., of pressure release and freeze-trapping is of the order of 5-10 s, with the limiting factor being the speed of pressure release: if pressure is released too vigorously, turbulence within the cell may blow the protein crystal out of its cryoloop.
While this design has a number of positive features, e.g. simplicity of design and use, the possibility to observe the crystal during exposure to xenon to detect drying, cracking or clathrate formation, it also has two shortcomings: there is a high xenon consumption which increases with pressure (the entire volume of cell and connection tubing has to be filled with pressurized gas), and the maximum pressure is limited by the pressure in the xenon gas bottle and by the maximum rating of the pressure reduction valve. Moreover, it was observed that rapid pressure release led to turbulence within the cell which occasionally blew the crystal off the loop. This motivated the design of the second type of pressure cell.
The 'mark 2'pressure cell
This design (Fig. 3 ) follows the general idea to separate xenon supply from the 'pressure-supply'. The device consists of a 500ram-long thick-walled glass tube of which one end (the left end in Fig. 3a ) is connected to the valve of a nitrogen gas bottle (or any other source of pressurized gas). The pin with the mounted cycle can be inserted into the tube at its opposite end (right), and sealed by pushing it with a lock-screw towards an appropriately shaped Teflon gasket. A drop of liquid mercury acts as a 'piston', separating the tube volume into a nitrogen-filled left part and a xenon-filled fight part. The idea of this device is to fill the tube with xenon gas (with the mercury drop in the far left position), insert the pin with crystal from the right, and apply nitrogen pressure from the left, which pushes the mercury piston towards the crystal and compresses the surrounding xenon gas.
Thus, in preparing this device for an experiment, the glass tube first has to be filled with xenon. For this purpose, a 'filling pin' (Fig. 3b ) is inserted in place of the X-ray pin. This filling pin has the same outside shape and dimensions as a normal crystal pin, but it is drilled through and closed with a rubber diaphragm. With this pin inserted and the pressure gas pipe disconnected, the gas volume to the right of the mercury drop can be extracted with a medical syringe whose needle is pushed through the rubber diaphragm. This moves the mercury drop all the way to the right of the glass tube. With another syringe, xenon gas (which has been saturated with water vapour by bubbling through water) is injected, pushing the mercury drop to the left and thereby filling the tube with xenon. This sequence of steps is repeated once or twice to completely displace the air in the right part of the tube and replace it by water-saturated xenon. Subsequently, with the tube in a vertical position, the filling pin can be taken out, without losing the xenon gas (which is much heavier than air). The device is now ready for accepting the X-ray pin with the protein crystal mounted in a drop of cryoprotectant. A special pin holder (Fig. 3c) is used for manipulating the pin and for fixing it within the xenon tube. After insertion of the pin, pressure is applied from the nitrogen pressure supply, which drives the mercury drop towards the crystal and compresses the surrounding xenon gas. The device has so far been used for xenon pressures up to 5.0 MPa, but it is suitable for pressures up to --~20.0 MPa with a xenon consumption of less than 10 ml of uncompressed gas per experiment.
To shock-freeze the crystal following its exposure to xenon, the valve at the nitrogen gas bottle is closed, and pressure is released by unscrewing the connection of the capillary tubing. Due to the expansion of the compressed xenon gas, the mercury drop moves away from the crystal. The lock screw is quickly unscrewed, and the pin and pin holder are pulled out and dumped into liquid nitrogen. Again, the time between the beginning of pressure release and dumping the pin into liquid nitrogen is well below 10s. Since the expansion of the compressed xenon gas is more uniform than in the 'mark 1' device, the danger of losing the crystal by gas turbulence is less and pressure can be released correspondingly faster.
Both instruments have their specific merits and drawbacks. The 'mark 1' pressure cell is simpler in the handling and permits observation of the crystal during xenon exposure, but has a high xenon gas consumption (up to 11 of uncompressed gas per experiment) and allows pressures up to only about 1.0 MPa. The 'mark 2' device uses only a few millilitres of uncompressed gas per experiment, allows higher pressures (without a concomitantly higher gas consumption), but does not offer observation of the crystal during exposure to xenon, and is more complicated to build and to operate.
Both instruments were used for the experiments described below: experiments with xenon pressures below 1.0 MPa were carried out with the 'mark 1' pressure cell, which was historically the first instrument in our laboratory. Experiments with pressures above 1.0 MPa used the 'mark 2' device. Owing to its versatility and economy of use, this instrument has now almost completely replaced the 'mark 1' cell in our laboratory, even for experiments with lower xenon pressures.
Experimental
Monoclinic (P21) crystals of sperm-whale metmyoglobin were grown at pH 6.9 with 75% ammonium sulfate as precipitant. Crystals had an approximate size of 0.3 x 0.3 x 0.5mm. We are indebted to Dr llme Schlichting for making these crystals available to us.
For the two room-temperature experiments (1 and 3) , a crystal was mounted inside a 0.7mm X-ray quartz capillary, together with a small meniscus of mother liquor. Before mounting of the protein crystal, the capillary was glued into a special metal fitting, with which it could be attached to the pressure valve of a xenon gas bottle. The design of this attachment is similar to the one described by SPF. After collecting a native data set, the capillary was flushed with xenon, and a second data set was collected from the same crystal with a xenon pressure of 0.5 MPa applied throughout data collection.
For the low-temperature experiments, crystals were transferred from the mother liquor into a cryoprotectant obtained by mixing 85 l.tl of mother liquor with 15 tal of glycerol. For the native data set (experiment 2), the crystal was left in this cryoprotectant for several minutes, picked up with a cryoloop and shock cooled by dumping into liquid nitrosen. For the other experiments, the crystal was immediately picked up from the cryoprotectant and inserted into the xenon pressure cell. The 'mark 1' instrument was used for experiments 4-7, the other experiments were carried out with the 'mark 2' device. The handling of these instruments was performed as described above for each of the two devices. The time between the beginning of pressure release and shock freezing (the row entitled 'Delay' in Table 1 ) was kept as short as possible in each experiment, with the exception of experiment 6, where the crystal was intentionally kept within the pressure cell after pressure release for about 30 s and for an additional 10 s outside the pressure cell to obtain a rough estimate for the speed of xenon desorption. All crystal manipulation, soaking and xenon-exposure steps were carried out at ambient temperatures [295 (2) K].
X-ray data were collected with a Siemens three-circle diffractometer equipped with a multiwire area detector, mounted on a Siemens rotating-anode X-ray generator. Typical generator settings were 40kV/80mA with a 0.3 x 3 mm focal spot; for larger crystals the tube current had to be reduced owing to detector overload. A copper target was used in combination with a graphite monochromator 7 (Cu K~)= 1.54 ,~] and a 0.3 mm collimator. For low-temperature diffraction experiments we used a locally constructed nitrogen gas-stream cryostat. The data-collection temperatures given in Table 1 were recorded with a PT 100 temperature sensor located about 5 mm upstream from the crystal. For each experiment listed in Table 1 , diffraction data were collected to a resolution of ~ 2 A. With a crystalto-detector distance of 100 mm, several sweeps with the detector at different 20 angles had to be performed. A typical sweep consisted of 900 consecutive o9 oscillations (Am = 0.2°). Data were processed with the XDS program package (Kabsch, 1988 (Kabsch, , 1993 ; the subsequent crystallographic computations were carried out with the CCP4 program suite (Collaborative Computational Project, Number 4, 1994) and with the X-PLOR package (Briinger, 1992) . Phasing statistics were obtained from program MLPHARE from the CCP4 package.
After extraction of structure factors from the observed data frames, a molecular-replacement structure solution was performed with coordinates from the Brookhaven Protein Data Bank (Bernstein et al., 1977; entry 4mbn, Takano, 1977 ; excluding solvent positions), followed by a rigid-body refinement, using the reflections between 2.5 and 15 A. With this model, which showed R values between 0.27 and 0.36, calculated structure factors and phases were computed for the reflections in the above resolution shell. These phases were used for the (Fxe-Fnat) difference-Fourier maps of Fig. 4 . The xenon positions were determined from (F o -F¢) maps, which showed solvent density plus the xenon peaks. The latter were identified with reference to the data given by TKP. Occupancies were refined (X-PLOR) with data between 3 and 15,&. No attempt was made to refine occupancies and B values for the xenon positions simultaneously. Instead, the B values were set to 12 .~2 for the low-temperature data and to 20A, 2 for the room-temperature data, and the occupancies were allowed to refine, together with the positional coordinates. Whenever an occupancy exceeded 1.0, it was fixed at 1.0 and the B value was allowed to refine. The values for the phasing power shown in Table 1 were computed from Xel for a resolution shell between 4.5 and 7.5A, after scaling native and derivative data between 3 and 20A. These data were also used to compute the resolution dependence of the merging R value shown in Fig. 5 .
Results and discussion

Binding of xenon to myoglobin
The application of the xenon freeze-trapping technique is demonstrated with experiments on the binding of xenon to the monoclinic crystal form of sperm-whale metmyoglobin. We have chosen this protein because extensive room-temperature reference data are available from the work of TKP. The application of this technique to other proteins will be published elsewhere.
The results of all experiments on metmyoglobin crystals are summarized in Table 1. In the design of these experiments we intended to demonstrate the feasibility and power of the freeze-trapping technique rather than to comprehensively investigate the interaction between myoglobin and xenon. For reference purposes, we also collected two native data sets (experiments 1 and 2), one at room temperature (1) and a second one at cryotemperature. The room-temperature data collection was performed on a crystal mounted within the quartz capillary of a high-pressure cell similar to the device described by SPF. Following collection of the native data set (experiment 1), a second room-temperature data set was collected from the same crystal with 0.5 MPa xenon pressure applied (experiment 3).
The four xenon binding sites
TKP have comprehensively investigated the binding of xenon to myoglobin at room temperature, and they have observed four xenon binding sites, of which only site 1 is fully occupied at a xenon pressure of --~ 0.7 MPa. In all our experiments, at room temperature and at cryotemperature, we find the same four sites, and we also only observe site 1 to be fully occupied (Table 1) . Xel is bound within the heme pocket near the proximal side of the corrin ring; the other three sites fill interior cavities within the protein.
In contrast to TKP, we made no attempt to refine B values and occupancies simultaneously for the xenon sites in view of the strong correlation between these two quantities (average correlation coefficient 0.95, with a unit increase in B roughly being equivalent to a decrease in the occupancy by 1.3%). Since we were more interested in observing possible changes in occupancies rather than getting good absolute values, we followed the strategy of fixing the B values of all four xenon positions to what we considered reasonable values (20 and 12 A2 for the room-temperature and low-temperature data, respectively) and refined the occupancy parameters. Whenever the occupancy refined to a value exceeding 1.0 it was fixed to 1.0 and the B value was allowed to refine. Compared with TKP our room-temperature occupancies came out lower for sites 2--4, since they allowed higher B values for these sites. Table 2 gives the coordinates of the four xenon sites, obtained by averaging the results of the seven lowtemperature xenon experiments, together with standard deviations calculated from the deviations of individual coordinates from the respective mean. These deviations are largest for Xe2, which is in qualitative agreement with the results of TKP, who obtained a particularly large B value for this site. Fig. 4 shows a Fourier section passing through the main xenon binding site. Experimental difference-Fourier maps computed from data collected at room temperature (a) and low temperature (b) are shown together with a map computed from anomalous differences (c). The three maps display a high degree of similarity. Similar results (not shown) are obtained for the other xenon binding sites. It thus appears that, at least in the case of sperm-whale metmyoglobin, cryo- Fig. 4 . Room-temperature (a) and low-temperature (b) difference-electron map and Fourier maps of anomalous differences (c) for myogiobin. All maps show a section through the Xel binding site (Y/b = 0.36), contoured at 1.26 increments (first contour at 1.25). Differences [Fx~ -Fnat] with phases from a molecular-replacement structure solution (see experimental part) were used for the summation for (a) and (b); map (c) was computed from differences between anomalous pairs using the same phases. (a) Differences between structure factors from experiment 10 (Fxe) and experiment 2 (F, at). (b) Differences between experiment 3 and experiment 1. (c) Anomalous differences from experiment 10. All maps were computed with program FFT from the CCP4 package (Collaborative Computational Project, Number 4, 1994) . cooling does not detectably alter the protein's xenonbinding properties.
Low-temperature versus room-temperature xenon binding
Xenon adsorption and desorption kinetics
Few data are available concerning the rate of xenon adsorption or desorption. Previous experiments involved several hours of exposure to xenon before the onset of a diffraction experiment (Schoenborn, Watson & Kendrew, 1965; TKP; Vitali, Robbins, Almo & Tilton, 1991 ). However, SPF were able to show that the kinetics of xenon uptake are more in the order of minutes. Although we also did not (yet) undertake a systematic kinetic investigation (we note, however, that the freezetrapping technique is very well suited for such an undertaking), all our data agree with the observation of SPF. While our earlier experiments still involved exposure times of up to 60min (see Table 1 ), we obtained full occupation of the Xel site after as little as 3min exposure to xenon in the high-pressure experiments.
While the xenon uptake is thus remarkably fast, the reverse process, xenon desorption, appears to be surprisingly slow. This is already evident from the fact that the freeze-trapping technique works at all, with several seconds delay between the start of xenon pressure release and freeze-trapping, of which the crystal is "-~ 1 s outside the pressure cell. Comparison of the occupancies of the four xenon sites between the room-temperature experiments 3 (which involved recording the diffraction pattern under 0.5 MPa xenon pressure) and experiments 4, 5 and 7 (which involved freeze-trapping after exposure to a similar xenon pressure) shows a small and possibly insignificant decrease, pointing at very little, if any, xenon desorption before freeze trapping. We also performed one experiment (number 6) in which we intentionally prolonged the time between xenon pressure release and shock freezing to 40 s. For the first 30 of these 40 s, the crystal was left inside the pressure cell (which was still filled with uncompressed xenon gas); subsequently it was left for another 10 s in air prior to shock freezing. Compared with the other experiments without such a delay, the four xenon binding sites show lower occupancies, but the decrease is only of the order of 20% for the sum of the four occupancies, which we consider remarkably small.
Occupation of xenon sites
In their seminal paper on the binding of xenon to sperm-whale metmyoglobin, TKP raised the interesting question of cooperative interaction between the partially occupied binding sites Xe2, Xe3 and Xe4, i.e. whether these three sites can be independently populated in each molecule, or whether binding of xenon to one of sites 2-4 decreases the affinity of the other two sites (e.g. by locking the protein in a conformational substate upon xenon binding).
Since our data extend to xenon pressures of ~.5.0 MPa, almost an order of magnitude higher than in previous experiments, we would expect a concomitant increase in the occupation of any of the partly populated sites (2-4) if there were no cooperativity between them. The data indeed show that (excluding experiment 6) there is a slight increase in the sum of the four occupancies with increasing pressure. While, in agreement with previous experiments, site 1 is already fully occupied at xenon pressures below 1.0 MPa, each of the other three sites remains partly occupied up to 5.0 MPa. The sum of the four population parameters increases slightly between 0.75 and 5.0 MPa, from about 2 to 2.4, which is still far below the limiting value of 4.0 expected at very high pressures for uncooperative binding to all four sites. Therefore, it appears that the data argue in favour of cooperativity between sites 2, 3 and 4, i.e. that the three sites cannot be simultaneously occupied in any one metmyoglobin molecule.
We note that this evidence does not constitute unequivocal proof of cooperativity, since the time of xenon exposure was shorter for the high-pressure experiments. However, the strong increase with increasing pressure in the R factor (between native data and xenon derivatives, see Fig. 5 ) for the low-resolution reflections strongly indicates (see below) that indeed there is much more xenon dissolved within the solvent regions of the metmyoglobin crystals after high-pres-484 FREEZE-TRAPPING ISOMORPHOUS XENON DERIVATIVES OF PROTEIN CRYSTALS sure xenon exposure, in spite of the shorter exposure times.
The effect on low-angle reflections
In addition to its use as a heavy atom for isomorphous replacement, xenon suggests itself as an ideal agent to modify the density of the crystal-included solvent regions without affecting protein conformation or crystal packing. Already Bragg & Perutz (1952) have demonstrated that experiments of this kind are a potential source of low-resolution phase information. Since changing the electron density of a protein crystal's mother liquor without corrupting its integrity is difficult, the use of contrast variation for low-resolution phasing has so far been largely the domain of neutron diffraction Bentley, Lewit-Bentley, Finch, Podjarny & Roth, 1984; Moras et al., 1983; Podjarny et al., 1987) . Here, the neutron-scattering cross section of water can easily be changed by admixing D20. However, contrast variation has also successfully been used with X-rays, where anomalous differences may yield phase information (Carter et al., 1990) . Of particular interest are also recent experiments to change the solvent contrast by changing the X-ray wavelength across the absorption edge of a buffer constituent, called the MASC method (multiwavelength anomalous solvent contrast; Fourme et al., 1996) .
Owing to the high solubility of xenon in water (241 and 108 cm 3 1-l of xenon at 0.1 MPa gas pressure at 273 and 293 K, respectively; Weast & Astle, 1980) and the even higher solubility in organic solvents (Pollack et al., 1989) , appreciable concentrations of dissolved xenon can be achieved at elevated xenon pressures. Thus, from the solubility of xenon in pure water one can estimate that the concentration of dissolved xenon exceeds 0.1 M at 298 K and 5.0 MPa (Kennan & Pollack, 1990) . Provided the xenon concentration within the crystal is as large as in the mother liquor, the considerable alteration of the electron density of the disordered solvent should result in concomitant intensity changes of low-angle reflections. Fig. 5 shows the merging R value between intensities from crystals exposed to xenon at two different pressures (experiments 4 and 10) and native crystals (experiment 2), plotted as a function of resolution. While the two experiments show a very similar resolution-dependence of the merging R values for the highangle reflections (resolution range between 2.5 and 10 A), the R values deviate considerably for the loworder intensities, with the 5.2 MPa experiment resulting in much larger deviations than the 0.75 MPa experiment. It is indeed very likely that this dramatic effect of the high xenon pressure on the low-order terms is due to the change in the electron density of the solvent region due to dissolved xenon. In fact, difference electron-density maps for the two high-pressure experiments show a considerable number of peaks at the surface of the protein, which are not observed in the other maps. Some of these peaks are likely to originate from xenon positions with high B values.
We plan to repeat and extend the high-pressure experiments with special emphasis on collecting accurate and extensive (i.e. including anomalous pairs) loworder reflections, and to examine the use of freezetrapped dissolved xenon for the purpose of obtaining or improving phase information, as well as extending this kind of experiment to other gases, such as krypton.
Clathrate formation
The formation of solid xenon hydrates [typically of composition Xes(H20)46] from supersaturated aqueous xenon solutions is a well known potential obstacle against the use of xenon as a heavy atom for isomorphous replacement (SPF). Clathrate formation is thermodynamically well characterized for the two-phase system consisting of pure water and gaseous xenon (Forcrand, 1925; Braun, 1938) , the pressure/temperature diagram of which (Fig. 6) shows that, at 293 K, clathrates begining to form at xenon pressures of 1.2 MPa. This might appear to render any experiment involving higher xenon pressures hopeless, but there are several factors which weaken the verdict of thermodynamics.
Firstly, it is very likely (Petsko, 1975; Pollack et al., 1989 ) that the clathrate formation curve shitts towards higher pressures upon the addition of salts or organic solvents, which makes Fig. 6 a 'lower limit' for all practical purposes. Secondly, clathrate formation is a crystallization process which is subject to phase inhibition due to the requirements of nucleation. Although no kinetic data are available, it has been observed by us and by others (e.g. SPF) that the onset of clathrate formation is slow and typically takes hours. Thirdly, while the xenon concentration inside a solid xenon clathrate (McMullan & Kvick, 1990 ) is around 8M, the con- Braun (1938) (dashed line) and to de Forcrand (1925) (full line).
centration of xenon dissolved in aqueous solution at pressures below 5.0 MPa is at least one order of magnitude lower, i.e. between 0.1 and 0.2M at 5.0 MPa and 298 K in pure water (Kennan & Pollack, 1990 ). Therefore, clathrate formation initially only converts a few percent of the total liquid volume into solid; further conversion requires the uptake of more xenon from the gas phase, which is subject to slowdown by diffusion. While clathrate formation is thus a serious obstacle against observing xenon complexes at temperatures above 273 K and at pressures above the clathrate formation limit (Fig. 6) , it can easily be avoided when using the freeze-trapping technique by choosing a sufficiently short xenon exposure time. In none of the experiments described in this communication did we ever encounter problems originating from the formation of xenon hydrates.
Xenon as a heavy atom in macromolecular crystallography
In many respects xenon is thus a very attractive heavy atom for producing isomorphous derivatives of macromolecular crystals, particularly when used together with the freeze-trapping technique. Very high xenon concentrations (well into the molar range) can be attained, yet the nature and strength of the interactions between xenon and proteins does not appear to affect crystal contacts resulting in loss of isomorphicity. The dependence of unit-cell volumes on the xenon pressure for the low-temperature experiments (Table 1) shows no systematic trend. High phasing powers (see Table 1 ) are the results of the good isomorphicity, permitting the computation of a reasonable set of phases from a single xenon derivative by SIRAS (Vitali, Robbins, Almo & Tilton, 1991) .
In applying the xenon freeze-trapping technique for the preparation of isomorphous derivatives, we now routinely use the 'mark 2' instrument with a xenon pressure of 4.0-5.0 MPa for 2-4 min. The very short exposure time diminishes the risk of crystal damage by drying or clathrate formation. No difficulties were encountered when carrying out the xenon exposure in the cold room. In fact, due to the increase in xenon solubility with decreasing temperature (Pollack et al., 1989) we prefer to work at 269 K whenever protein crystals are stable under these conditions. Xenon freezetrapping experiments with other proteins will be described elsewhere.
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